1. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. Issue 12 (December 2022) Authors: Keir, Holly R; Long, Merete B; Abo-Leyah, Hani; Giam, Yan Hui; Vadiveloo, Thenmalar; Pembridge, Thomas; Hull, Rebecca C; Delgado, Lilia; Band, Margaret; McLaren-Neil, Fiona; Adamson, Simon; Lahnsteiner, Eva; Gilmour, Amy; Hughes, Chloe; New, Benjamin JM; Connell, David; Dowey, Rebecca; Turton, He... Journal: Lancet Issue: Volume 10:Issue 12(2022) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modelling cumulative exposure for inference about drug effects in observational studies. Issue 12 (12th October 2017) Authors: Farran, Bassam; McGurnaghan, Stuart; Looker, Helen C.; Livingstone, Shona; Lahnsteiner, Eva; Colhoun, Helen M.; McKeigue, Paul M. Journal: Pharmacoepidemiology and drug safety Issue: Volume 26:Issue 12(2017) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗